首页> 美国卫生研究院文献>other >Targeted Drug Delivery with Focused Ultrasound-Induced Blood-Brain Barrier Opening Using Acoustically-Activated Nanodroplets
【2h】

Targeted Drug Delivery with Focused Ultrasound-Induced Blood-Brain Barrier Opening Using Acoustically-Activated Nanodroplets

机译:使用声激活纳米液滴聚焦超声诱导的血脑屏障开放的靶向药物递送。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Focused ultrasound (FUS) in the presence of systemically administered microbubbles has been shown to locally, transiently and reversibly increase the permeability of the blood-brain barrier (BBB), thus allowing targeted delivery of therapeutic agents in the brain for the treatment of central nervous system diseases. Currently, microbubbles are the only agents that have been used to facilitate the FUS-induced BBB opening. However, they are constrained within the intravascular space due to their micron-size diameters, limiting the delivery effect at or near the microvessels. In the present study, acoustically-activated nanodroplets were used as a new class of contrast agents to mediate FUS-induced BBB opening in order to study the feasibility of utilizing these nanoscale phase-shift particles for targeted drug delivery in the brain. Significant dextran delivery was achieved in the mouse hippocampus using nanodroplets at clinically relevant pressures. Passive cavitation detection was used in the attempt to establish a correlation between the amount of dextran delivered in the brain and the acoustic emission recorded during sonication. Conventional microbubbles with the same lipid shell composition and perfluorobutane core as the nanodroplets were also used to compare the efficiency of FUS-induced dextran delivery. It was found that nanodroplets had a higher BBB opening pressure threshold but a lower stable cavitation threshold than microbubbles, suggesting that contrast agent-dependent acoustic emission monitoring was needed. More homogeneous dextran delivery within the targeted hippocampus was achieved using nanodroplets without inducing inertial cavitation or compromising safety. Our results offered a new means of developing the FUS-induced BBB opening technology for potential extravascular targeted drug delivery in the brain, extending the potential drug delivery region beyond the cerebral vasculature.
机译:研究表明,在全身施用微泡的情况下,聚焦超声(FUS)可以局部,瞬时和可逆地增加血脑屏障(BBB)的通透性,从而可以在脑中靶向递送治疗剂以治疗中枢神经系统疾病。当前,微泡是唯一已用于促进FUS诱导的BBB开放的药物。然而,由于它们的微米尺寸直径,它们被限制在血管内空间内,限制了在微血管处或附近的递送效果。在本研究中,声激活的纳米液滴被用作一类新的造影剂,以介导FUS诱导的BBB开放,以研究利用这些纳米级相移颗粒在大脑中靶向药物递送的可行性。在临床相关压力下使用纳米液滴在小鼠海马体中实现了显着的右旋糖酐递送。为了确定在大脑中传递的右旋糖酐的量与声波处理期间记录的声发射之间的相关性,使用了被动空化检测。具有与纳米液滴相同的脂质壳组成和全氟丁烷核心的常规微泡也用于比较FUS诱导的葡聚糖递送的效率。已发现,与微泡相比,纳米液滴的BBB开启压力阈值更高,但稳定的空化阈值更低,这表明需要依赖造影剂的声发射监测。使用纳米液滴可以在目标海马体内实现更均匀的右旋糖酐递送,而不会引起惯性空化或损害安全性。我们的结果为开发FUS诱导的BBB开放技术提供了一种新的方法,该技术可将潜在的血管外靶向药物输送到大脑,从而将潜在的药物输送区域扩展到脑血管之外。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号